# NV Therapeutics, Inc. — Form D

NV Therapeutics, Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-14. The offering totals $7.5M, of which $3.0M was reported sold. Industry: Other.

## Offering

- Filed: 2025-03-14
- Form: D
- Accession: 0002060599-25-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $3.0M
- Remaining: $4.5M
- Investors: 1
- Date of first sale: 2024-09-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-540884

## Issuer

- Name: NV Therapeutics, Inc.
- CIK: 0002060599
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 2625 DURANT AVENUE, BERKELEY, CA, 94720
- Phone: 6177782500

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Daniel Dever | Director | Berkeley, CA |
| Kevin Holden | Director | Berkeley, CA |
| Audrey Kozlov | Director | Berkeley, CA |
| Dmitry Kuzmin | Director | St Peter Port, Y7 |
| Kevin Holden | Executive Officer | Berkeley, CA |
| Kevin Holden | Promoter | Berkeley, CA |

## More

- [CIK 2060599 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2060599&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002060599-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.